期刊文献+

Zn(N_2O_2)型锌配合物及L-茶氨酸锌与糖尿病关系的研究进展 被引量:4

Progress in relations of zinc compounds with Zn(N_2O_2) coordination mode and L-theanine-zinc with diabetes mellitus
下载PDF
导出
摘要 锌及其配合物具有类胰岛素作用,并且生物兼容性强,稳定性好及体内外降糖作用明显。自发现锌化合物具有类胰岛素作用以来,锌配合物及其抗糖尿病作用受到国内外学者的热切关注。锌在体内参与糖类和脂质代谢等生理生化过程,锌及其配合物抗糖尿病作用机制主要包括直接参与胰岛素合成、抗氧化、参与调控酪氨酸蛋白磷酸化酶和提高免疫功能等。具有Zn(N2O2)配合型的锌配合物有较好的类胰岛素作用,其中,L-茶氨酸锌是具有天然配基的一类锌配合物,对糖尿病模型小鼠有显著降糖作用,且化学性质稳定,体内吸收快,口服无副作用。本文就锌及其配合物在抗糖尿病应用方面的进展进行综述。 Zinc and its compounds with insulin-like effects have been found to own such properties as strong bio-compatibility,good stability and remarkable hypoglycemic effect. Since the discovery of their insulin-like function,zinc compounds and their anti-diabetic effects have been a geobal focus of research. Zinc ion is involved in physiological and biochemical processes in vivo,such as in carbohy-drate and lipid metabolism. The mechanism of zinc and zinc complexes in anti-diabetic activity are sum-marized in this article,including direct participation in insulin synthesis,antioxidation,involvement in the regulation of tyrosine protein phosphatase,and improving immunity. Zinc complexes with Zn(N2O2 )have remarkable insulin-like effects. Particularly,the L-theanine-zinc compound,which is a class of zinc com-plexes with natural ligands,has also been found to show significant hypoglycemic effect in an in vivo experiment on KK-Ay mice,have stable chemical properties,be absorbed fast in vivoand be non-toxic with oral administration during model animal experiments. This paper reviews the progress in research on relationships between zinc and its complexes and the anti-diabetic effect.
出处 《中国药理学与毒理学杂志》 CAS CSCD 北大核心 2014年第5期774-778,共5页 Chinese Journal of Pharmacology and Toxicology
关键词 L-茶氨酸 类胰岛素活性 糖尿病 锌配合物 L-theanine insulinomimetic activity diabetes mellitus zinc compound
  • 相关文献

参考文献31

  • 1Jayawardena R, Ranasinghe P, Galappatthy P, Malkanthi R, Constantine G, Katulanda P. Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis [ J ]. Diabetol Metab Syndr, 2012, 4(1) .13. 被引量:1
  • 2Jansen J, Karges W, Rink L. Zinc and diabetes- clinical links and molecular mechanisms [ J ]. J Nutr Biochem, 2009, 20(6).399-417. 被引量:1
  • 3Cousins RJ. Zinc[ M]//Ziegler EE, Filer LJ. Present Knowledge in Nutrition. 7th ed. Washington DC. International Life Science Institute Nutrition Foun- dation, 1996:290-306. 被引量:1
  • 4Overbeck S, Uciechowski P, Ackland ML, Ford D, Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9 [ J ]. J Leukoc Biol, 2008, 83 (2): 368-380. 被引量:1
  • 5Scott DA. Crystalline insulin [ J ]. Biochem J, 1934, 28(4) ;1592-1602. 被引量:1
  • 6Coulston L, Dandona P. Insulin-like effect of zinc on adipooytes[J]. Diabetes, 1980, 29(8):665-667. 被引量:1
  • 7Chen MD, Liou SJ, Lin PY, Yang VC, Alexander PS, Lin WH. Effects of zinc supplementation on the plasma glucose level and insulin activity in genetically obese (ob/ob) mice [ J ]. Biol Trace Elem Res, 1998, 61(3) :303-311. 被引量:1
  • 8Shisheva A, Gefel D, Shechter Y. Insulinlike effects of zinc ion in vitro and in vivo. Preferential effects on desensitized adipocytes and induction of normoglycemia in streptozocin-induced rats [ J ]. Diabetes, 1992, 41 (8) : 982-988. 被引量:1
  • 9Yoshikawa Y, Ueda E, Kawabe K, Miyake H, Saku- rai H, Kojima Y. New insulin-mimetic zinc(Ⅱ) comple- xes: bis-maltolato zinc(Ⅱ) and bis-2-hydroxypyridine- N-oxido zinc(Ⅱ) with Zn(O4) coordination mode[J]. Chem Lett, 2000, 29(8) .874-875. 被引量:1
  • 10Adachi Y, Yoshida J, Kodera Y, Kato A, Yoshika- wa Y, Kojima Y, et aL A new insulin-mimetic bis (allixinato) zinc(Ⅱ ) complex: structure-activity re- lationship of zinc( Ⅱ) complexes[J]. J Biol Inorg Chem, 2004, 9 (7) : 885-893. 被引量:1

同被引文献43

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部